Your browser doesn't support javascript.
loading
Lupeol, an androgen receptor inhibitor, enhances the chemosensitivity of prostate cancer stem cells to antiandrogen enzalutamide-based therapy.
Khan, Mohammad Afsar; Singh, Deepti; Jameel, Mohd; Maurya, Santosh K; Singh, Swati; Akhtar, Kafil; Siddique, Hifzur R.
Affiliation
  • Khan MA; Molecular Cancer Genetics & Translational Research Lab, Section of Genetics, Department of Zoology, Aligarh Muslim University, Aligarh 202002, India.
  • Singh D; Molecular Cancer Genetics & Translational Research Lab, Section of Genetics, Department of Zoology, Aligarh Muslim University, Aligarh 202002, India.
  • Jameel M; Molecular Cancer Genetics & Translational Research Lab, Section of Genetics, Department of Zoology, Aligarh Muslim University, Aligarh 202002, India.
  • Maurya SK; Molecular Cancer Genetics & Translational Research Lab, Section of Genetics, Department of Zoology, Aligarh Muslim University, Aligarh 202002, India.
  • Singh S; Department of Zoology, University of Delhi, Delhi 110007, India.
  • Akhtar K; Department of Pathology, JNMC, Aligarh 202002, India.
  • Siddique HR; Molecular Cancer Genetics & Translational Research Lab, Section of Genetics, Department of Zoology, Aligarh Muslim University, Aligarh 202002, India. Electronic address: hrsiddique@gmail.com.
Toxicol Appl Pharmacol ; 478: 116699, 2023 11 01.
Article in En | MEDLINE | ID: mdl-37777120
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Receptors, Androgen / Prostatic Neoplasms, Castration-Resistant Limits: Animals / Humans / Male Language: En Journal: Toxicol Appl Pharmacol Year: 2023 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Receptors, Androgen / Prostatic Neoplasms, Castration-Resistant Limits: Animals / Humans / Male Language: En Journal: Toxicol Appl Pharmacol Year: 2023 Document type: Article Affiliation country: Country of publication: